3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia (Q71927489)
scientific article published on 01 January 1996
Language:
Current Data About 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia
(P31) (Q13442814)
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

(P304) 295-299
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

(P433) 4
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

(P478) 74
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

(P577) Monday, January 1, 1996
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

(P921) (Q954625)
(P887)

(Q264118)
(P887)

(P1433) (Q45134122)
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

(P1476) "3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia" (language: en)
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

(P2093) G Shi
(P1545) 1
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

H J Weh
(P1545) 2
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

S Martensen
(P1545) 3
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

D Seeger
(P1545) 4
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

D K Hossfeld
(P1545) 5
(P248)
(P698) 8976389
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8976389%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 22, 2019

other details
description scientific article published on 01 January 1996

External Links
(P356) 10.1159/000134439
(P698) 8976389